These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25285238)

  • 1. Nef-M1, a CXCR4 Peptide Antagonist, Enhances Apoptosis and Inhibits Primary Tumor Growth and Metastasis in Breast Cancer.
    Bumpers H; Huang MB; Katkoori V; Manne U; Bond V
    J Cancer Ther; 2013 Jun; 4(4):898-906. PubMed ID: 25285238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.
    Katkoori VR; Basson MD; Bond VC; Manne U; Bumpers HL
    Oncotarget; 2015 Sep; 6(29):27763-77. PubMed ID: 26318034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV Nef-M1 Effects on Colorectal Cancer Growth in Tumor-induced Spleens and Hepatic Metastasis.
    Harrington W; Bond V; Huang MB; Powell M; Lillard J; Manne U; Bumpers H
    Mol Cell Pharmacol; 2009 Aug; 1(2):85-91. PubMed ID: 20383296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Nef-CXCR4 interactions important for apoptosis induction.
    Huang MB; Jin LL; James CO; Khan M; Powell MD; Bond VC
    J Virol; 2004 Oct; 78(20):11084-96. PubMed ID: 15452229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small molecule CXCR4 antagonists block the HIV-1 Nef/CXCR4 axis and selectively initiate the apoptotic program in breast cancer cells.
    Huang MB; Giesler KE; Katzman BM; Prosser AR; Truax V; Liotta DC; Wilson LJ; Bond VC
    Oncotarget; 2018 Mar; 9(24):16996-17013. PubMed ID: 29682200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular Nef protein targets CD4+ T cells for apoptosis by interacting with CXCR4 surface receptors.
    James CO; Huang MB; Khan M; Garcia-Barrio M; Powell MD; Bond VC
    J Virol; 2004 Mar; 78(6):3099-109. PubMed ID: 14990729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCL12-CXCR4 axis promotes the natural selection of breast cancer cell metastasis.
    Sun Y; Mao X; Fan C; Liu C; Guo A; Guan S; Jin Q; Li B; Yao F; Jin F
    Tumour Biol; 2014 Aug; 35(8):7765-73. PubMed ID: 24810923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gonadotropin-releasing hormone type II antagonist induces apoptosis in MCF-7 and triple-negative MDA-MB-231 human breast cancer cells in vitro and in vivo.
    Gründker C; Föst C; Fister S; Nolte N; Günthert AR; Emons G
    Breast Cancer Res; 2010; 12(4):R49. PubMed ID: 20630060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bifunctional fused polypeptide inhibits the growth and metastasis of breast cancer.
    Liang AL; Qian HL; Zhang TT; Zhou N; Wang HJ; Men XT; Qi W; Zhang PP; Fu M; Liang X; Lin C; Liu YJ
    Drug Des Devel Ther; 2015; 9():5671-86. PubMed ID: 26527862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A CXCR4 antagonist CTCE-9908 inhibits primary tumor growth and metastasis of breast cancer.
    Huang EH; Singh B; Cristofanilli M; Gelovani J; Wei C; Vincent L; Cook KR; Lucci A
    J Surg Res; 2009 Aug; 155(2):231-6. PubMed ID: 19482312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer-derived exosomes regulate cell invasion and metastasis in breast cancer via miR-146a to activate cancer associated fibroblasts in tumor microenvironment.
    Yang SS; Ma S; Dou H; Liu F; Zhang SY; Jiang C; Xiao M; Huang YX
    Exp Cell Res; 2020 Jun; 391(2):111983. PubMed ID: 32268136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretion modification region-derived peptide blocks exosome release and mediates cell cycle arrest in breast cancer cells.
    Huang MB; Gonzalez RR; Lillard J; Bond VC
    Oncotarget; 2017 Feb; 8(7):11302-11315. PubMed ID: 28076321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
    Kang H; Mansel RE; Jiang WG
    Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic Knockout of CXCR4 Expression by a Novel Intrakine Mutant hSDF-1α/54/KDEL Inhibits Breast Cancer Metastasis.
    Chen HY; Clayman ES; Ma WF
    J Interferon Cytokine Res; 2015 Oct; 35(10):771-8. PubMed ID: 25978539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of SDF-1-CXCR4 signaling on microRNA expression and tumorigenesis in estrogen receptor-alpha (ER-α)-positive breast cancer cells.
    Rhodes LV; Bratton MR; Zhu Y; Tilghman SL; Muir SE; Salvo VA; Tate CR; Elliott S; Nephew KP; Collins-Burow BM; Burow ME
    Exp Cell Res; 2011 Nov; 317(18):2573-81. PubMed ID: 21906588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neferine inhibits MDA-MB-231 cells growth and metastasis by regulating miR-374a/FGFR-2.
    Liu Z; Zhang S; Wang T; Shao H; Gao J; Wang Y; Ge Y
    Chem Biol Interact; 2019 Aug; 309():108716. PubMed ID: 31207222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of p21WAF1/CIP1 in human breast cancer cell lines MCF-7 and MDA-MB-468 undergoing apoptosis induced by natural product anticancer drugs 10-hydroxycamptothecin and camptothecin through p53-dependent and independent pathways.
    Liu W; Zhang R
    Int J Oncol; 1998 Apr; 12(4):793-804. PubMed ID: 9499438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of LY2510924, a novel cyclic peptide CXCR4 antagonist that exhibits antitumor activities in solid tumor and breast cancer metastatic models.
    Peng SB; Zhang X; Paul D; Kays LM; Gough W; Stewart J; Uhlik MT; Chen Q; Hui YH; Zamek-Gliszczynski MJ; Wijsman JA; Credille KM; Yan LZ
    Mol Cancer Ther; 2015 Feb; 14(2):480-90. PubMed ID: 25504752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptotic peptides derived from HIV-1 Nef induce lymphocyte depletion in mice.
    Huang MB; James CO; Powell MD; Bond VC
    Ethn Dis; 2008; 18(2 Suppl 2):S2-30-7. PubMed ID: 18646317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transendothelial migration of two metastatic breast carcinoma cells depend on the SDF-lalpha-CXCR4 complexes.
    Lechertier T; Berard M; Vassy R; Herve MA; Crepin M
    Anticancer Res; 2004; 24(6):4011-7. PubMed ID: 15739262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.